Mr. Speaker, I congratulate the hon. member for bringing this important bill to the House. I believe that the problem is going to grow even bigger in the next decades. Hundreds of thousands of Canadians may be faced with something like this.
I have a technical question. Canada already has a national strategy for drugs for rare diseases. Bill S-201, which we are discussing today, focuses only on a single rare disease. Does the hon. member believe that this framework would contradict the existing law we have in place?